Monocytes represent one source of bacterial shielding from antibiotics following influenza virus infection

Karl J. Fischer, Vijaya Kumar Yajjala, Shruti Bansal, Christopher Bauer, Ruiling Chen, Keer Sun

Research output: Contribution to journalArticle

Abstract

Methicillin-resistant Staphylococcus aureus has emerged as a significant contributor to morbidity and mortality associated with influenza infection. In this study, we show in a mouse model that preceding influenza infection promotes S. aureus resistance to killing by antibiotics. This resistance coincides with influenza-induced accumulation of inflammatory monocytes in the lung. CCR type 2 (CCR2) is responsible for pulmonary monocyte recruitment after influenza infection. We found that antibiotic-treated Ccr2-deficient (Ccr2 -/- ) mice exhibit significantly improved bacterial control and survival from influenza and methicillinresistant S. aureus coinfection, despite a delay in viral clearance. Mechanistically, our results from in vivo studies indicate that influenza-induced monocytes serve as reservoirs for intracellular S. aureus survival, thereby promoting bacterial resistance to antibiotic treatment. Blocking CCR2 with a small molecular inhibitor (PF-04178903), in conjunction with antibiotic treatment, enhanced lung bacterial clearance and significantly improved animal survival. Collectively, our study demonstrates that inflammatory monocytes constitute an important and hitherto underappreciated mechanism of the conflicting immune requirements for viral and bacterial clearance by hosts, which subsequently leads to exacerbated outcomes of influenza and S. aureus coinfection.

Original languageEnglish (US)
Pages (from-to)2027-2034
Number of pages8
JournalJournal of Immunology
Volume202
Issue number7
DOIs
StatePublished - Jan 1 2019

Fingerprint

Virus Diseases
Orthomyxoviridae
Human Influenza
Monocytes
Anti-Bacterial Agents
Staphylococcus aureus
Coinfection
Lung
Infection
Bacterial Drug Resistance
Methicillin-Resistant Staphylococcus aureus
Morbidity
Mortality

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Monocytes represent one source of bacterial shielding from antibiotics following influenza virus infection. / Fischer, Karl J.; Yajjala, Vijaya Kumar; Bansal, Shruti; Bauer, Christopher; Chen, Ruiling; Sun, Keer.

In: Journal of Immunology, Vol. 202, No. 7, 01.01.2019, p. 2027-2034.

Research output: Contribution to journalArticle

Fischer, Karl J. ; Yajjala, Vijaya Kumar ; Bansal, Shruti ; Bauer, Christopher ; Chen, Ruiling ; Sun, Keer. / Monocytes represent one source of bacterial shielding from antibiotics following influenza virus infection. In: Journal of Immunology. 2019 ; Vol. 202, No. 7. pp. 2027-2034.
@article{1efe69391fb44b02bb83cd4007fd698c,
title = "Monocytes represent one source of bacterial shielding from antibiotics following influenza virus infection",
abstract = "Methicillin-resistant Staphylococcus aureus has emerged as a significant contributor to morbidity and mortality associated with influenza infection. In this study, we show in a mouse model that preceding influenza infection promotes S. aureus resistance to killing by antibiotics. This resistance coincides with influenza-induced accumulation of inflammatory monocytes in the lung. CCR type 2 (CCR2) is responsible for pulmonary monocyte recruitment after influenza infection. We found that antibiotic-treated Ccr2-deficient (Ccr2 -/- ) mice exhibit significantly improved bacterial control and survival from influenza and methicillinresistant S. aureus coinfection, despite a delay in viral clearance. Mechanistically, our results from in vivo studies indicate that influenza-induced monocytes serve as reservoirs for intracellular S. aureus survival, thereby promoting bacterial resistance to antibiotic treatment. Blocking CCR2 with a small molecular inhibitor (PF-04178903), in conjunction with antibiotic treatment, enhanced lung bacterial clearance and significantly improved animal survival. Collectively, our study demonstrates that inflammatory monocytes constitute an important and hitherto underappreciated mechanism of the conflicting immune requirements for viral and bacterial clearance by hosts, which subsequently leads to exacerbated outcomes of influenza and S. aureus coinfection.",
author = "Fischer, {Karl J.} and Yajjala, {Vijaya Kumar} and Shruti Bansal and Christopher Bauer and Ruiling Chen and Keer Sun",
year = "2019",
month = "1",
day = "1",
doi = "10.4049/jimmunol.1801471",
language = "English (US)",
volume = "202",
pages = "2027--2034",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "7",

}

TY - JOUR

T1 - Monocytes represent one source of bacterial shielding from antibiotics following influenza virus infection

AU - Fischer, Karl J.

AU - Yajjala, Vijaya Kumar

AU - Bansal, Shruti

AU - Bauer, Christopher

AU - Chen, Ruiling

AU - Sun, Keer

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Methicillin-resistant Staphylococcus aureus has emerged as a significant contributor to morbidity and mortality associated with influenza infection. In this study, we show in a mouse model that preceding influenza infection promotes S. aureus resistance to killing by antibiotics. This resistance coincides with influenza-induced accumulation of inflammatory monocytes in the lung. CCR type 2 (CCR2) is responsible for pulmonary monocyte recruitment after influenza infection. We found that antibiotic-treated Ccr2-deficient (Ccr2 -/- ) mice exhibit significantly improved bacterial control and survival from influenza and methicillinresistant S. aureus coinfection, despite a delay in viral clearance. Mechanistically, our results from in vivo studies indicate that influenza-induced monocytes serve as reservoirs for intracellular S. aureus survival, thereby promoting bacterial resistance to antibiotic treatment. Blocking CCR2 with a small molecular inhibitor (PF-04178903), in conjunction with antibiotic treatment, enhanced lung bacterial clearance and significantly improved animal survival. Collectively, our study demonstrates that inflammatory monocytes constitute an important and hitherto underappreciated mechanism of the conflicting immune requirements for viral and bacterial clearance by hosts, which subsequently leads to exacerbated outcomes of influenza and S. aureus coinfection.

AB - Methicillin-resistant Staphylococcus aureus has emerged as a significant contributor to morbidity and mortality associated with influenza infection. In this study, we show in a mouse model that preceding influenza infection promotes S. aureus resistance to killing by antibiotics. This resistance coincides with influenza-induced accumulation of inflammatory monocytes in the lung. CCR type 2 (CCR2) is responsible for pulmonary monocyte recruitment after influenza infection. We found that antibiotic-treated Ccr2-deficient (Ccr2 -/- ) mice exhibit significantly improved bacterial control and survival from influenza and methicillinresistant S. aureus coinfection, despite a delay in viral clearance. Mechanistically, our results from in vivo studies indicate that influenza-induced monocytes serve as reservoirs for intracellular S. aureus survival, thereby promoting bacterial resistance to antibiotic treatment. Blocking CCR2 with a small molecular inhibitor (PF-04178903), in conjunction with antibiotic treatment, enhanced lung bacterial clearance and significantly improved animal survival. Collectively, our study demonstrates that inflammatory monocytes constitute an important and hitherto underappreciated mechanism of the conflicting immune requirements for viral and bacterial clearance by hosts, which subsequently leads to exacerbated outcomes of influenza and S. aureus coinfection.

UR - http://www.scopus.com/inward/record.url?scp=85063261675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063261675&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1801471

DO - 10.4049/jimmunol.1801471

M3 - Article

VL - 202

SP - 2027

EP - 2034

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 7

ER -